Aptose Biosciences Inc.’s License Agreement with Hanmi Pharmaceutical

Aptose Biosciences Inc.'s License Agreement with Hanmi Pharmaceutical

McCarthy Tétrault advised Aptose Biosciences on the deal. Aptose Biosciences Inc. has entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239. Under the…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now